Nhs Counter Fraud Authority: From 1 Different Sources
(NHSCFA) a *special health authority formed in 2017 to identify, investigate, and prevent fraud, bribery, and corruption within NHS organizations in England. These functions were formerly carried out by NHS Protect, part of the *NHS Business Services Authority.
NHS Counter Fraud Authority website
An agent which produces vaso-dilation of peripheral blood vessels by stimulating nerve-endings of the skin to generate irritation intended to relieve deep-seated pain. Arnica, Balm of Gilead, Black Mustard, Bryony (white), Cajuput (oil of), Camphor, Canada Balsam, Cayenne, Eucalyptus, Nutmeg (oil of), Sassafras, Thuja. ... counter irritant
See ASSISTED CONCEPTION.... human fertilisation & embryology authority (hfea)
This body manages regional TRANSFUSION centres. Among its aims are the maintenance and promotion of blood and blood products based on a system of voluntary donors; implementing a cost-e?ective national strategy for ensuring adequate supplies of blood and its products to meet national needs; and ensuring high standards of safety and quality.... national blood authority
See MEDICAL LITIGATION.... nhs litigation authority
A description applied in the UK to MEDICINES and drugs that can be obtained from a pharmacist without a doctor’s or dentist’s prescription. Some medications may be bought from retail outlets other than pharmacists.... over-the-counter (otc)
Research misconduct is de?ned as behaviour by a researcher that falls short of good ethical and scienti?c standards – whether or not this be intentional. For example, the same data may be sent for publication to more than one medical journal, which might have the e?ect of their being counted twice in any META-ANALYSIS or systematic review; or the data may be ‘salami sliced’ to try to make the maximum number of publications, even though the data may overlap. Fraud in the context of research is de?ned as the generation of false data with the intent to deceive. It is much less frequent than carelessness, but its incidence is estimated as between
0.1 and 1 per cent. A ?gure of 1 per cent means that, in the United Kingdom at any one time, maybe 30 studies are being conducted, or their results published, which could contain false information. Examples include forged ethics-committee approval, patient signatures and diary cards; fabricated ?gures and results; invention of non-existent patient subjects; or sharing one electrocardiogram or blood sample amongst many subjects.
Research fraud should be ?rst suspected by a clinical-trial monitor who recognises that data are not genuine, or by a quality-assurance auditor who cannot reconcile data in clinical-trial report forms with original patient records. Unfortunately, it often comes to light by chance. There may be suspicious similarities between data ostensibly coming from more than one source, or visits may have been recorded when it was known that the clinic was shut. Statistical analysis of a likely irregularity will frequently con?rm such suspicion. The motivation for fraud is usually greed, but a desire to publish at all costs, to be the original author of a medical breakthrough, to bolster applications for research grants, or to strengthen a bid for more departmental resources are other recognised reasons for committing fraud.
In the USA, those proved to have committed fraud are debarred from receiving federal funds for research purposes or from undertaking government-funded therapeutic research. The four Nordic countries (Denmark, Finland, Norway and Sweden) have committees on research dishonesty that investigate all cases of suspected research misconduct. In the United Kingdom, an informal system operated by the pharmaceutical industry, using the disciplinary mechanism of the General Medical Council (GMC), has led to more than 16 doctors in the past ten years being disciplined for having committed research fraud. Editors of many of the world’s leading medical journals have united to form the Committee on Publishing Ethics, which advises doctors on proper practice and assists them in retracting or refusing to publish articles found or known to be false. (See ETHICS; ETHICS COMMITTEES.) Where an author does not o?er a satisfactory explanation, the matter is passed to his or her institution to investigate; where an editor or the committee is not satis?ed with the result they may pass the complaint to the appropriate regulatory body, such as the GMC in Britain.... research fraud and misconduct
In the UK, this NHS authority (UKTSSA) provides a 24-hour service for matching, allocating and distributing organs. It is also responsible for keeping the records of all patients awaiting transplants. Established in 1991, the authority allocates donor organs without favour, following protocols set by advisory groups. It also administers the Human Organ Transplant Act on behalf of the Department of Health. (See TRANSPLANTATION.)... transplant support services authority
Herbal products are chiefly used to relieve symptoms of self- limiting conditions. Such products are either P (pharmacy only) or GSL (General Sales List). The Medicines (Labelling and Advertising to the Public) Regulations 1978 (SI 1978 No 41) state the range of conditions on schedule 2, parts I-IV. Dried herbs on sale under their plant or botanical name over the counter are exempt, provided no medicinal claims are made. ... over-the-counter products
(OTC) drug A drug that can be bought without a prescription at a chemist’s or other store.... over-the-counter
see National Health Service.... health authority
a *special health authority of the NHS established following the Health and Social Care Act 2012 to promote and protect the interests of patients in health research and to simplify the regulation of research. The Health Research Authority inherited the functions of the National Research Ethics Service, which closed in 2012.... health research authority
the UK government agency, established by the Human Tissue Act 2004, that regulates the removal, use, and storage of human organs and tissue from both the living and the deceased for certain purposes as defined by the statute. These purposes include clinical research, clinical audit, and medical education. Anyone handling such material for those purposes should have a licence issued by the authority. Membership of the authority comprises clinical, scientific, academic, and lay representatives.... human tissue authority
(NHSPSA) see NHS Business Services Authority.... nhs prescription services authority
formerly, a *special health authority of the NHS established under the Health and Social Care Act 2012 to oversee NHS trusts without *foundation trust status and to support their transition to such status. The Authority closed in 2016, when its functions were transferred to the newly established *NHS Improvement.... nhs trust development authority
(OTC drug) a drug that may be purchased directly from a pharmacist without a doctor’s prescription. Current government policy is to extend the range of OTC drugs: a number have already been derestricted (e.g. ibuprofen, ranitidine) and this trend is increasing, which will place an additional advisory responsibility on pharmacists.... over-the-counter drug
a device to measure and record the fluorescent flashes in a *scintillator exposed to high-energy radiation.... scintillation counter
a type of NHS trust that provides services across the NHS in England, rather than in a single defined geographical area. There are four special health authorities, which exist as arms-length bodies of the Department of Health and Social Care, independent of government: *NHS Blood and Transplant, *NHS Business Services Authority, *NHS Resolution and *NHS Counter Fraud Authority.... special health authority
(SHA) formerly a statutory organization in England that was responsible for strategic leadership, building capacity, organizational development, and performance management in the local National Health Service. SHAs were abolished by the Health and Social Care Act 2012; their responsibilities passed to *NHS England, *clinical commissioning groups, and *Public Health England.... strategic health authority
Health Encyclopedia